Table 1 Resistance phenotypes of MRSA
Resistance profile | No. (%) of isolates |
|---|---|
Individual antibiotics | |
Erythromycin | 70 (47.9) |
Ciprofloxacin | 62 (42.5) |
Clindamycin (including inducible resistance) | 45 (30.8) |
(Inducible Clindamycin resistance) | 20 (13.7)) |
Tetracycline | 32 (21.9) |
Gentamicin | 23 (15.6) |
Sulfamethoxazole/trimethoprim | 8 (5.4) |
Rifampicin | 7 (4.8) |
Vancomycin | 0 (0) |
Multiresistance | |
Oxacillin + 1 antibiotic | 42 (28.8) |
Ciprofloxacin | 16 (11.0) |
Erythromycin | 10 (6.8) |
Tetracycline | 9 (6.1) |
Gentamycin | 6 (4.1) |
Sulfamethoxazole/trimethoprim | 1 (0.7) |
Oxacillin + 2 antibiotics | 22 (15.1) |
Ciprofloxacin + erythromycin | 7 (4.8) |
Clindamycin + erythromycin | 6 (4.1) |
Erythromycin + tetracycline | 3 (2.1) |
Other combinations* | 6 (4.1) |
Oxacillin + 3 antibiotics | 29 (19.7) |
Ciprofloxacin + clindamycin + erythromycin | 16 (11.0) |
Ciprofloxacin + erythromycin + tetracyclin | 7 (4.8) |
Other combinations* | 6 (4.1) |
Oxacillin + 4 antibiotics | 11 (7.5) |
Ciprofloxacin + clindamycin + erythromycin + gentamicin | 6 (4.1) |
Other combinations* | 5 (3.5) |
Oxacillin + 5 antibiotics* | 1 (0.7) |
Oxacillin + 6 antibiotics* | 4 (2.7) |
Ciprofloxacin + clindamycin + erythromycin + tetracyclin + rifampicin + gentamicin | 3 (2.1) |